Cargando…
CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer
Triple-negative breast cancer (TNBC) occurs in approximately 15% of all breast cancer patients, and the incidence of TNBC is greatly increased in BRCA1 mutation carriers. This study aimed to assess the impact of BRCA1 promoter methylation with respect to breast cancer subtypes in sporadic disease. T...
Autores principales: | Stefansson, Olafur Andri, Jonasson, Jon Gunnlaugur, Olafsdottir, Kristrun, Hilmarsdottir, Holmfridur, Olafsdottir, Gudridur, Esteller, Manel, Johannsson, Oskar Thor, Eyfjord, Jorunn Erla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121973/ https://www.ncbi.nlm.nih.gov/pubmed/21593597 http://dx.doi.org/10.4161/epi.6.5.15667 |
Ejemplares similares
-
Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes
por: Stefansson, Olafur Andri, et al.
Publicado: (2009) -
Correction: Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes
por: Stefansson, Olafur Andri, et al.
Publicado: (2009) -
BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy
por: Stefansson, Olafur A, et al.
Publicado: (2019) -
A DNA methylation‐based definition of biologically distinct breast cancer subtypes
por: Stefansson, Olafur A., et al.
Publicado: (2014) -
CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer
por: Stefansson, Olafur Andri, et al.
Publicado: (2017)